• Japanese
  • Korean
  • Chinese
Cover Image

Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014

GlobalData's clinical trial report, "Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Small-Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Small-Cell Lung Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Small-Cell Lung Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Small-Cell Lung Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Small-Cell Lung Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Small-Cell Lung Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Small-Cell Lung Cancer
    • Nov 05, 2013: ImmunoGen Announces Discontinuation of IMGN901 Study in Small-Cell Lung Cancer
    • Oct 24, 2013: Cornerstone Pharmaceuticals Announces Initiation of Phase II Clinical Trial of CPI-613 for the Treatment of Small Cell Lung Cancer
    • Oct 24, 2013: Nektar and Roswell Park Cancer Institute Announce Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol as a Second-Line Treatment in Patients with Relapsed or Refractory Small Cell Lung Cancer
    • Oct 21, 2013: New Nanopharmaceutical May Help Overcome Resistance to Certain Anticancer Drugs
    • Jun 11, 2013: Critical Outcome Technologies Announces Positive Preclinical Results Of Cancer Drug Candidiate COTI-2 Against p53 Gene Mutations
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Sarah Cannon Research Institute
      • Clinical Trial Overview of Sarah Cannon Research Institute
      • NCIC Clinical Trials Group
      • Clinical Trial Overview of NCIC Clinical Trials Group
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Radiation Therapy Oncology Group
      • Clinical Trial Overview of Radiation Therapy Oncology Group
      • Southeastern Medical Oncology Center
      • Clinical Trial Overview of Southeastern Medical Oncology Center
      • Japan Clinical Oncology Group
      • Clinical Trial Overview of Japan Clinical Oncology Group
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Clinical Oncology Group, 2014*

List of Figures

  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Show More
Pricing
Get Notified
Email me when related reports are published